Online business breakfast ‘Challenges the State and the Pharmaceutical
Industry Face Today’ took place on 2 June 2020. The Roscongress
Foundation and The Content Foundation for the Development of Expert and
Analytical Activity organized the event.
In the context of the coronavirus pandemic, the Roscongress Foundation
carried on the tradition and held a business breakfast with representatives of
government, community and the pharmaceutical industry in a new online format on
the traditional days of the SPIEF. The Subcommittee on the Circulation of
Medicinal Products and the Development of the Pharmaceutical and Medical
Industry of the State Duma Committee on Health Protection supported the event
and CDA became the organizational partner.
The event was attended by the Head of the Federal Service for
Surveillance in Healthcare (Roszdravnadzor) Alla Samoylova, Director of the
Department of Drug Supply and Regulation of Medical Devices at the Ministry of
Health of the Russian Federation Elena Maksimkina, Head of the Federal Service
for Intellectual Property Grigory Ivliev, General Manager of Merck Biopharma
Russia and CIS Matthias Wernicke, as well as representatives of the
pharmaceutical industry. Aleksandr Petrov, Deputy, Member of the Committee of
the State Duma of the Federal Assembly of the Russian Federation on Health
Protection moderated the business breakfast.
The event discussed strategies applied both within the pharmaceutical
industry and relevant government departments and authorities in response to the
challenges of the coronavirus pandemic. The business breakfast participants
talked about the state support measures for the pharmaceutical industry,
localization of production as a strategy to ensure uninterrupted supply of
medicines, ways to simplify the drugs registration procedures and introduction
into clinical practice. As an advanced measure, the Federal Service for
Intellectual Property (Rospatent) announced the coming up establishment of a
unified Eurasian register of pharmacologically active substances.
“It is important for us not only to guarantee patent protection to all
inventors and patent holders, but we also need effective tools of such
protection. Therefore, I hope that a unified Eurasian registry will be created
in the near future to be maintained by Rospatent and the Ministry of Health.
The copyright holder will receive the right to provide rights records to be
entered in the Register. This would allow correlating it with the information
on previously registered drugs and patents, and, based on this, determine the
marketability of newly registered substances. The Register is also intended to
aid the fight against coronavirus as it is to ensure the quick launch of newly
discovered drugs and test systems, as well as protect the rights of patent
holders,” commented Head of the Service Grigory Ivliev.
The event participants noted how the pharmaceutical market players and
public authorities engaged in a productive dialogue and maintained communication,
which became an essential ground for success during the pandemic. “Both parties
are looking forward to the continuation of such a dialogue. Market participants
and government officials agreed on the need to consolidate the best practices
of cooperation gained during the pandemic and to expand it in the post-crisis
period,” First Deputy Director
for Development, and Head of Healthcare Projects Directorate at the Roscongress
Foundation Anastasia Stolkova said.